Figure 6.
Cumulative rates of minimal residual disease over time (in bone marrow or peripheral blood). Clb: chlorambucil; Ibr: ibrutinib; MRD: minimal residual disease; Ob: obinutuzumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.